AOTMiT: What will the Transparency Council address in May?

TRANSPARENCY COUNCIL MEETING NO. 18/2023 MAY 8, 2023

1. Pediatric Emergency Care Decision-making problem: preparing a position on the qualification of a health care service as a guaranteed benefit

2. Wakix (pitolisantum) - CONDITIONAL Indication: in adults suffering from narcolepsy with or without cataplexy Decision problem: preparing a position paper on the evaluation of the drug

3. Vabysmo (farycymabum) - CONDITIONAL Indication: under the drug program "Treatment of patients with retinal diseases" Decision problem: preparation of a position paper on the evaluation of the drug

4. velireg (belzutifan) Indication: von Hippel-Lindau syndrome (VHL), von Hippel-Lindau syndrome (VHL) for high-risk radiotherapy and surgical treatment of tumors Decision problem: preparing a position paper on the appropriateness of reimbursement approvals

5. "Health policy program of the City of Skarżysko-Kamienna for 2023-2025 in the field of medical rehabilitation". "Health policy program in support of infertility treatment by in vitro fertilization method - in vitro for residents of the Municipality of Zhukowice in 2023-2026". Decision-making problem: preparation of opinions on draft health policy programs of local government units

6. "Health policy program on prevention of tobacco (nicotine) addiction". Decision-making problem: preparation of opinions on recommended medical technologies, activities carried out within the framework of health policy programs and the conditions for their implementation

TRANSPARENCY COUNCIL MEETING NO. 19/2023 MAY 15, 2023

1. adtralza (tralokinumabum) Indication: within the framework of the drug program "Treatment of patients with severe forms of atopic dermatitis" - adolescents Decision problem: preparation of a position paper on the evaluation of the drug

2. Forxiga (dapagliflozinum) - CONDITIONAL Indication: treatment of adult patients diagnosed with chronic kidney disease with eGFR <60 ml/min/1.73m2 and with albuminuria or proteinuria and treatment with ACE-i/ARB-based therapy for not less than 4 weeks or with contraindications to these therapies Decision problem: preparation of a position paper on the evaluation of the drug

3. lonsurf (trifluridinum + tipiracilum) - CONDITIONAL Indication: under drug program B.58 "Treatment of advanced gastric cancer (ICD-10: C16)" Decision-making problem: preparation of a position paper on the evaluation of the drug

4. fentanylum Indication: breakthrough pain in children with cancer who are receiving opioid maintenance therapy as part of the treatment of chronic cancer pain and for whom there are documented contraindications to the use of other short-acting opioids or the ineffectiveness of these drugs has been established Decision problem: preparation of an opinion on continuation of reimbursement coverage in off-label indications

5. desmopressinum Indication: primary isolated bedwetting in patients between 5-6 years of age with normal urinary thickening capacity after documented failure of 1-month supportive and incentive management Decision problem: preparation of opinion on continuation of reimbursement coverage in off-label indications

6. "Orthoptic diagnostic examination of children aged 5-8 in the Piaseczno Municipality". "Rehabilitation of residents of the Municipality of Kamieniec Ząbkowicki for 2023-2025". Decision-making problem: preparation of opinions on draft health policy programs of local government units

TRANSPARENCY COUNCIL MEETING NO. 20/2023 MAY 22, 2023

1. adtralza (tralokinumabum) - CONDITIONAL Indication: under drug program B.124. "Treatment of patients with severe forms of atopic dermatitis (ICD-10: L20)" Decision-making problem: preparation of a position paper on the evaluation of the drug

2. opdivo (nivolumabum) - CONDITIONAL Indication: under the drug program "Treatment of patients with urothelial carcinoma (ICD-10: C61, C65, C66, C67, C68)". Decision-making problem: preparation of a position paper on the evaluation of the drug

3. "Subsidy for infertility treatment by in vitro fertilization for residents of the city of Zduńska Wola for 2023". "Treatment of infertility by in vitro fertilization for residents of the city of Bialystok in 2023 implemented from the Citizens' Budget 2023". 3 Decision-making problem: preparation of opinions on draft health policy programs of local government units

TRANSPARENCY COUNCIL MEETING NO. 21/2023 MAY 29, 2023

1. comprehensive specialist care for patients allergic to hymenopterous insect venom and inhalant allergens Decision problem: preparation of a position paper on the appropriateness of introducing comprehensive specialist care into the guaranteed services

2. cabometyx (cabozantinibum) Indication: under drug program B.119. "Treatment of patients with progressive, locally advanced or metastatic, differentiated (papillary/alveolar/oxophilic -from hürthle cells) thyroid cancer refractory to radioactive iodine treatment (ICD-10 C 73)." Decision problem: preparing a position paper on drug evaluation

(3) Lynparza (olaparibum) Indication: under drug program B.9.FM. "Treatment of patients with breast cancer (ICD-10: C50)". Decision-making problem: preparing a position paper on the evaluation of the drug

4. Lipistart- CONDITIONAL Indication: LCHAD deficit, VLCAD deficit, CPT I deficit, CPT II deficit, ascites lymphoma, heart defect - post-cardiac treatment condition Decision problem: preparation of a position on the appropriateness of issuing reimbursement approvals.

Source: AOTMiT